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Mycobacterium  fortuitum  as  a cause  of peritoneal  dialysis
catheter port  infection.  A clinical  case and  a review  of the
literature
Mycobacterium  fortuitum  como  causa  de  infección  del  oriﬁcio  del
catéter  de  diálisis  peritoneal.  Caso  clínico  y  revisión  de  la  literaturaperitonitis in one patient and with the infection of subcuta-Dear Editor,
Catheter-related infections are a common and clinically rel-
evant in peritoneal dialysis patients. Exit-site infections are
characterized by the presence of purulent discharge, with or
without local. The most common pathogens are Staphylococcus
and Gram-negative bacteria; however, rapidly growing atypi-
cal mycobacteria (RGAM) are rare.
Here we  describe a paediatric patient with a Mycobacterium
fortuitum peritoneal catheter exit-site infection together with
literature review.
He is a 4-year-old boy with a 4-month history of continu-
ous ambulatory peritoneal dialysis (CAPD). He complained of
erythema in the peritoneal catheter exit site, with mild dis-
charge and no improvement following 7 days of treatment
with topical mupirocin. After sampling for exudate culture,
topical therapy with ciproﬂoxacin was initiated. Six days later
the erythema was still present and the patient developed a
chocolate-coloured discharge and a granuloma was observed
(Fig. 1). The patient was asympyomatic with no fever. Blood
chemistry did not show an increase in acute-phase reactants,
and cytochemistry of peritoneal ﬂuid was normal. Previous
culture was positive for RGAM. Intraperitoneal ciproﬂoxacin
and amikacin were initiated, together local care of the exist
site with Betadine®. The Mycobacteria was subsequently clas-
siﬁed as Mycobacterium fortuitum sensitive to both antibotics,
ciproﬂoxacin and amikacin. Treatment was continued for 8
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2015;35:584–586.weeks and culture became negative, with low improvement of
the exit site appearance (Fig. 1). Thus, it was decided to replace
the Tenckhoff catheter, despite no evidence of peritonitis. The
patient continued under CAPD with no acceptable ultraﬁltra-
tion. The patient was naïve to systemic antibiotics and had no
history of previous infections before this episode.
The incidence of RGAM infections has increased during the
last years, this group of Mycobacteria is widespread, and with-
out nutrients and over wide-ranging temperatures. The most
prevalent RGAMs involved in human infections include: M.
fortuitum, Mycobacterium chelonae, Mycobacterium mucogenicum,
Mycobacterium abscessus, and Mycobacterium marinum,1 with
the ﬁrst two most commonly resulting in peritoneal dialysis
catheter infections.
We  have found twenty-three cases reported of RGAM infec-
tions of the peritoneal catheter exit site were identiﬁed in
10 English and Spanish articles published between 1990 and
2011,2–11 including a paediatric patient.2 The most common
microorganism, as in our patient was M.  fortuitum, followed
by M.  chenolae, and M. abscessus. Infection was associated withíz Serrano MJ, Morales San-José MD, Luque de Pablos A. Mycobac-
isis peritoneal. Caso clínico y revisión de la literatura. Nefrologia.
neous tract in 4 patients (Table 1).
Predisposing factors described are: immunesupression,
peritonitis resistant to several cycles of antibiotic, surgery,
accidental trauma, or injections.
Auramin or Ziehl-Neelsen staining techniques reveal the
acid-alcohol resistance of mycobacteria. A culture should

















Table 1 – Characteristics of patients on peritoneal
dialysis with exit-site infection by rapidly growing
non-tuberculous mycobacteria (N = 24).
Characteristics Number Percent
Organism
M. fortuitum 14 58.2
M. chenolae 5 20.8
M. abscessus 5  20.8
Appearance of the exit site (N = 16)
Purulent discharge 16/16 100
Granulation tissue 9/16 56.2
Abscess 5/16 31.2
Associated with peritonitis 1 4.1
Associated with catheter tunnel infection 4 16.6
Requiring catheter replacement 16 66.7
Switch to HD (N = 23 patients)
Yes (temporal or permanent) 12/23 52.1
No 11/23 47.8
in all cases showing peritonitis or tunnel infection, patients
with M.  abcessus infection, and 80% of M.  chenolae infections.
More  than 50% of patients had to be on haemodialysis.
In light of the extensive variability reported in terms of
antibiotic resistance, species should be accurately screened
in vitro for sensitivity to certain antibiotics so a right therapy
can be established. Medium microdilution is recommended
for determining sensitivity; a faster commercial technique, E-
test, has been introduced in recent years, with an outstanding
correlation with the reference method. An empirical ther-
apy may include a combined therapy with aminoglycosides
(amikacin), macrolides (clarithromycin and azithromycin),
and ﬂuoroquinolones (although M.  chenolae and M. abscessus
may be resistant to the latter). Optimal treatment duration has
not been established yet, but ranged from one to six months in
our literature review. One case was cured after withdrawal of
topical gentamicin, which had been administered for 7 weeks,
rig. 1 – Top: erythema in the peritoneal dialysis catheter
xit site, with granuloma and chocolate-like discharge.
entre: appearance of the exit site at Week 2. Bottom:
ppearance of the exit site at Week 6 from the start of
argeted therapy.
e made in 2 speciﬁc media: a solid egg-based medium
Lowenstein-Jensen) and a liquid medium allowing for auto-
ated reading (MGIT, MB/BacT, ESP). Colony growth usually
ccurs within 7 days and is identiﬁed by means of faster
nd more  accurate phenotyping (biochemical tests) and
enotyping systems, based on the detection of species-speciﬁc
NA sequences.
RGAMs are relatively resistant to standard disinfectantsnd are able to generate bioﬁlms to survive. Consequently
n many  cases, peritoneal catheters must often be removed
r replaced. In our literature review the dialysis catheter was
eplaced in 65.2% of patients. The catheter was also removedand required no further antibiotic treatment.10
In conclusion RGAMs should be suspected in catheter
infections or peritonitis with negative cultures so as to pre-
vent a delay in diagnosis and decrease associated morbidity.
A large number of patients require replacement or removal of
the Tenckhoff catheter and should be switched to haemodial-
ysis.
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Resistant  anaemia  and  mixed
patient on  haemodialysis  in th
Anemia  resistente  y  crioglobulinem
hemodiálisis  en  contexto  de  ﬁebre
To the Editor,
Q  fever caused by Coxiella burnetti may produce acute or
chronic clinical manifestation, although most cases are
asymptomatic or mild.1 Acute presentation of Q fever is
characterised by a sudden ﬂu-like syndrome and high-grade
fever. Nearly 1–5% of infected patients develop a chronic
form, which can take place months or years after an acute
infection. The most common manifestation is endocarditis,
especially in immunocompromised patients or in patients
with valvular heart disease. Mixed cryoglobulinaemia is rare2,3
and can be diagnosed using an immunoassay. Seroconversion
is usually detected 7–15 days after the onset of symp-
toms. Titres of anti-phase II antigens IgG greater than 200
or Titres of anti-phase II antigens IgM greater than 50
are indicative of a recent infection, whereas titres of anti-
phase I antigens IgG greater than 800 are suggestive of
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yoglobulinaemia  in a
context  of Q  fever
 mixta  en  paciente  en
chronic infection. Mild forms are commonly self-limiting.
Doxycycline is the drug of choice if treatment is needed.
Hydroxychloroquine and doxycycline are recommended for
at least 18 months for the treatment of chronic forms of
endocarditis.
Our patient is a 64-year-old man  from Germany who  has
been living in Mallorca since 2011.
History:  HTN, ischaemic cardiomyopathy that underwent
revascularisation (3 stents). Atrial ﬁbrillation treated with
anticoagulation. Moderate alcoholism. End-stage chronic
renal disease (ESCRD) receiving haemodialysis with vascular
graft access. resistente y crioglobulinemia mixta en paciente en hemodiálisis
transaminases (GPT 124, GOT 114, and GGT 100), and posi-
tive CMV IgM. Following 2 weeks of treatment with ganciclovir,
the fever abated but the inﬂammatory parameters remained
high (CRP 9.24 and PCT 12.48). Fever recurred subsequently
